Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/4162
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Cost implications of the delivery of pharmaceutical care services through Australian community pharmacies
Author: Donato, R.
March, G.
Moss, J.
Gilbert, A.
Citation: International Journal of Pharmacy Practice, 2001; 9(1):23-30
Publisher: The Royal Pharmacuetical Society of Great Britain
Issue Date: 2001
ISSN: 0961-7671
2042-7174
Statement of
Responsibility: 
Ron Donato, Geoff March, John Moss and Andrew Gilbert
Abstract: OBJECTIVE — To conduct a cost analysis of the Community Pharmacy Model Practices project in South Australia. METHOD — As part of a prospective participatory action research programme, the cost analysis identified the main items of fixed and variable costs and of potential cost savings, and expressed them in a framework to aid decision-making. SETTING — Ten community pharmacy practices in primary care: five provided generalist medication management, two diabetes care, two asthma care, and one wound management. Services were provided to 411 pharmacy patients (median age 75; 70 per cent female) in the community, resident in a range of nursing home and hostel accommodation, or patients in hospital. There was a maximum of 11 months' observation. KEY FINDINGS — All the five medication management pharmacies, one of the asthma management pharmacies, and the wound management pharmacy, but neither of the diabetes management pharmacies, were able to generate potential resource savings greater than their total variable costs, so that net resource savings were available to make a contribution to absorbing fixed costs. CONCLUSION — The provision of medication management services by community pharmacies working to a well-defined, systematic process of patient care within a primary care setting can be expected to reduce overall direct costs to the health system. Similar findings are likely with wound management in pharmacy care, but the results are less certain for asthma management and diabetes management. These results, when considered in the light of possible gains in survival and quality of life, are of significant interest to policymakers concerned with controlling health system costs.
Rights: © Royal Pharmaceutical Society of Great Britain
DOI: 10.1111/j.2042-7174.2001.tb01025.x
Description (link): http://www.pharmacyabstracts.org/cgi-bin/details.pl?ID=11454
Published version: http://dx.doi.org/10.1111/j.2042-7174.2001.tb01025.x
Appears in Collections:Aurora harvest 6
Public Health publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.